Pharmacokinetics of Haloperidol in Critically Ill Patients: Is There an Association with Inflammation?

Haloperidol is considered the first-line treatment for delirium in critically ill patients. However, clinical evidence of efficacy is lacking and no pharmacokinetic studies have been performed in intensive care unit (ICU) patients. The aim of this study was to establish a pharmacokinetic model to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Letao, Sassen, Sebastiaan D. T., van der Jagt, Mathieu, Endeman, Henrik, Koch, Birgit C. P., Hunfeld, Nicole G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950491/
https://www.ncbi.nlm.nih.gov/pubmed/35335925
http://dx.doi.org/10.3390/pharmaceutics14030549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950491/
https://www.ncbi.nlm.nih.gov/pubmed/35335925
http://dx.doi.org/10.3390/pharmaceutics14030549

Ejemplares similares